Last reviewed · How we verify

Fluconazol — Competitive Intelligence Brief

Fluconazol (Fluconazol) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Infectious Disease.

marketed Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Fluconazol (Fluconazol) — Azienda Sanitaria-Universitaria Integrata di Udine.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fluconazol TARGET Fluconazol Azienda Sanitaria-Universitaria Integrata di Udine marketed Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase
Diflucan fluconazole Pfizer Inc. marketed Azole Antifungal [EPC] Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase 1990-01-29

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fluconazol — Competitive Intelligence Brief. https://druglandscape.com/ci/fluconazol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: